This image was uploaded in the JPEG format even though it consists of non-photographic data. This information could be stored more efficiently or accurately in the PNG or SVG format. If possible, please upload a PNG or SVG version of this image without compression artifacts, derived from a non-JPEG source (or with existing artifacts removed). After doing so, please tag the JPEG version with {{Superseded|NewImage.ext}} and remove this tag. This tag should not be applied to photographs or scans. If this image is a diagram or other image suitable for vectorisation, please tag this image with {{Convert to SVG}} instead of {{BadJPEG}}. If not suitable for vectorisation, use {{Convert to PNG}}. For more information, see {{BadJPEG}}.
File:Immune response2.svg is a vector version of this file. It should be used in place of this JPG file when not inferior.
The time course of an immune response. Immune reactants, such as antibodies and effector T-cells, work to eliminate an infection, and their levels and activity rapidly increase following an encounter with an infectious agent, whether that agent is a pathogen or a vaccine. For several weeks these reactants remain in the serum and lymphatic tissues and provide protective immunity against reinfection by the same agent. During an early reinfection, few outward symptoms of illness are present, but the levels of immune reactants increase and are detectable in the blood and/or lymph. Following clearance of the infection, antibody level and effector T-cell activity gradually declines. Because immunological memory has developed, reinfection at later time points leads to a rapid increase in antibody production and effector T cell activity. These later infections can be mild or even inapparent.
I, the copyright holder of this work, hereby publish it under the following licenses:
Permission is granted to copy, distribute and/or modify this document under the terms of the GNU Free Documentation License, Version 1.2 or any later version published by the Free Software Foundation; with no Invariant Sections, no Front-Cover Texts, and no Back-Cover Texts. A copy of the license is included in the section entitled GNU Free Documentation License.http://www.gnu.org/copyleft/fdl.htmlGFDLGNU Free Documentation Licensetruetrue
to share – to copy, distribute and transmit the work
to remix – to adapt the work
Under the following conditions:
attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
share alike – If you remix, transform, or build upon the material, you must distribute your contributions under the same or compatible license as the original.
This licensing tag was added to this file as part of the GFDL licensing update.http://creativecommons.org/licenses/by-sa/3.0/CC BY-SA 3.0Creative Commons Attribution-Share Alike 3.0truetrue
to share – to copy, distribute and transmit the work
to remix – to adapt the work
Under the following conditions:
attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
share alike – If you remix, transform, or build upon the material, you must distribute your contributions under the same or compatible license as the original.
{{Information |Description= The time course of an immune response. Immune reactants, such as antibody levels and effector T-cell activity, rapidly increase following encounter with an infectious agent, and work to eliminate the infection. Protective immun
File usage
No pages on the English Wikipedia use this file (pages on other projects are not listed).